Frequently Asked Questions about the IVI Draft Protocol for Major Depressive Disorder

The Innovation and Value Initiative welcomes public comments on its draft model protocol on major depressive disorder. The deadline to submit comments has been extended to Tuesday, January 25th. This economic model currently under development is part of IVI's Open-Source Value Project (OSVP). You can learn more about the model protocol through IVI's introductory [...]

2022-01-11T23:55:23-05:00January 11th, 2022|Blog|

Value In Medicaid, Part 2: Challenges Concerning Health-Related Social Needs

In the second of a two-part Health Affairs post, Dr. Anish Mahajan writes about several challenges concerning health-related social needs in the journey to value in Medicaid. He addresses challenges including use of social needs screening tools, case management infrastructure and workflow development. He also cites the need for further research to better align the health and social sectors [...]

2021-12-16T16:43:39-05:00December 16th, 2021|Blog, Health Affairs Blog Series|

Value In Medicaid, Part 1: Administrative, Regulatory, And Financial Challenges

Part 1 in a two-part blog series by Anish P. Mahajan, MD, the Chief Executive Officer of Harbor-UCLA Medical Center and Associate Dean at UCLA-Geffen School of Medicine, examines the administrative, regulatory, and financial challenges to achieving value in the Medicaid program. Read the full article here. The Innovation and Value Initiative (IVI) has [...]

2021-12-09T15:27:18-05:00December 9th, 2021|Blog, Health Affairs Blog Series|

Harmonization Of Health Technology Assessment Across The European Union: Lessons For The United States

In the latest piece of the IVI and Health Affairs blog series, Rosanna Tarricone and James Robinson compare the U.S. HTA landscape with experiences in Europe, using it to draw some lessons learned. The authors argue that we should be careful about any effort to centralize HTA. Instead, they recommend that we work on ways [...]

2021-12-02T19:16:16-05:00December 2nd, 2021|Blog, Health Affairs Blog Series|

Pursuing Health Care Value Post-COVID-19: Keep The Focus On Patients

At the midpoint of the Health Affairs and IVI blog series, PCORI's Nakela Cook discusses an essential lesson from the pandemic that must be applied to clinical research, healthcare delivery, and public health – patients must help drive the calculus that policymakers apply to building a more equitable, affordable healthcare system that delivers optimal outcomes. [...]

2021-11-19T16:10:31-05:00November 18th, 2021|Blog, Health Affairs Blog Series|

How Current Cost-Effectiveness Analyses Distort Drug Development Priorities

In the latest post in our ongoing series with Health Affairs blog, Soeren Mattke takes on the relationship value assessment and innovation of new therapies. He argues that cost-effectiveness analysis, one of the most common methods for economic assessments, may be distorting the incentives for investment in medical research and drug development. Specifically, he explains [...]

2021-11-16T17:25:11-05:00November 16th, 2021|Blog, Health Affairs Blog Series|

IVI MEMBER SPOTLIGHT: Danny van Leeuwen

This year we are pleased to welcome Danny van Leeuwen as a new member of the Innovation and Value Initiative. Danny is the host of HealthHats, a podcast and blog that helps people learn on the journey towards health. We were delighted that he took the time to speak with our own Jennifer [...]

2021-11-11T11:41:43-05:00November 9th, 2021|Blog, Member Spotlight|

Bolstering Our Ability To Value Health Technology: A Few Less-Considered Issues

AcademyHealth’s Michael E. Gluck authors the next in the IVI and Health Affairs blog series. He describes historical public efforts to implement HTA and how it “intersects with all of the major challenges facing US health care: cost, quality, access, equity, social determinants, and the tensions between the country’s dual commitments to innovation and health [...]

2021-11-10T14:05:09-05:00November 9th, 2021|Blog, Health Affairs Blog Series|

Fair Prices Should Lead To Fair Access: Why Is The Grand Bargain So Hard?

In a new post in our ongoing blog series with Health Affairs, ICER's Sarah Emond discusses the challenge of achieving a "grand bargain" in which fair prices and fair access provide optimal benefits to both patients and the health system. At the root, she argues, is the different and sometimes-conflicting perspectives, objectives, and incentives of the [...]

2021-11-02T17:13:44-04:00November 2nd, 2021|Blog, Health Affairs Blog Series|

The US Should Change Payment To Make Health Care More Equitable

The Health Affairs series continues with a post by Amol Navathe, Risa Lavizzo-Mourey and Joshua Laio examining how fee for service and risk-based payments fuel inequities and four ways we can set an explicit intention to use payments to eradicate inequities. The authors’ four recommendations: Form diverse coalitions with shared principles focused on payment Create [...]

2021-10-26T13:34:34-04:00October 26th, 2021|Blog, Health Affairs Blog Series|
Go to Top